Cleared Traditional

K231956 - F&P Optiflow+ Duet Nasal Cannula

K231956 is the FDA 510(k) clearance for F&P Optiflow+ Duet Nasal Cannula by Fisher &Paykel Healthcare , Ltd.. It is a Class 2 Anesthesiology device (product code BTT) cleared through the Traditional 510(k) pathway after a 219-day FDA review.

K231956 · Fisher &Paykel Healthcare , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2024
Decision
219d
Days
Class 2
Risk

K231956 is an FDA 510(k) clearance for the F&P Optiflow+ Duet Nasal Cannula. Classified as Humidifier, Respiratory Gas, (direct Patient Interface) (product code BTT), Class II - Special Controls.

Submitted by Fisher &Paykel Healthcare , Ltd. (Auckland, NZ). The FDA issued a Cleared decision on February 7, 2024 after a review of 219 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5450 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fisher &Paykel Healthcare , Ltd. devices

Submission Details

510(k) Number K231956 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2023
Decision Date February 07, 2024
Days to Decision 219 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d slower than avg
Panel avg: 140d · This submission: 219d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BTT Humidifier, Respiratory Gas, (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BTT Humidifier, Respiratory Gas, (direct Patient Interface)

All 81
Devices cleared under the same product code (BTT) and FDA review panel - the closest regulatory comparables to K231956.
HFT150
K233707 · Invent Medical Corporation · Jun 2024
F&P Optiflow Oxygen Kit (AA451J)
K233821 · Fisher &Paykel Healthcare , Ltd. · Jun 2024
F&P myAirvo 3
K222292 · Fisher & Paykel Healthcare · May 2024
Hudson RCI® Disposable Humidifier with 4 PSI Pressure Relief Valve (3230), Hudson RCI® Disposable Humidifier with 6 PSI Pressure Relief Valve (3260)
K230559 · Medline Industries, Inc. · Oct 2023
BONHAWA Respiratory Humidifier
K223863 · Telesair, Inc. · Oct 2023
F&P 820 Humidification System
K223684 · Fisher &Paykel Healthcare , Ltd. · Sep 2023